Corporate / M&A

Healthcare / Life Sciences

Tolremo-web-640x140

Homburger News

Share-Image Teamplate Deals-and-Cases

On September 20, 2023, TOLREMO therapeutics AG announced that it has completed its Series A financing, bringing the total amount raised to USD 39 m (CHF 34.1 m). BioMedPartners AG led the round with participation from a new investor, Pierre Fabre Invest, as well as existing investors.
TOLREMO&#8217;s mission is to stop non-genetic cancer drug resistance as it emerges by dismantling cancer&#8217;s earliest defenses to targeted therapies, thus surmounting a universal challenge for current and future targeted treatments.
The Homburger team was led by Dieter Gericke and Margrit Marti and comprised Francesco Bernasconi, Stefan Luginbühl, Thierry Burckhardt and Claudine Schär (all Corporate / M&amp;A; Healthcare / Life Sciences) as well as Stefan Oesterhelt (Tax).

Homburger advised TOLREMO therapeutics AG on the extension of its Series A financing round

Crown

On August 3, 2023, Crown Holdings, Inc., a leading global supplier of rigid packaging products to consumer marketing companies, as well as transit and protective packaging products, announced that it has signed a definitive agreement to acquire Helvetia Packaging AG, a Swiss supplier of sustainable aluminum beverage packaging with a manufacturing facility in Saarlouis, Germany. The transaction is subject to approval by German anti-trust authorities and is expected to be completed by the end of 2023.
Homburger AG has acted as Swiss counsel to Crown Packaging European Division GmbH on this transaction. The Homburger team was led by Daniel Hasler (Corporate / M&amp;A) and included Francesco Bernasconi (Corporate / M&amp;A), Bianca Nedwed (Corporate / M&amp;A) as well as Florian Bruggisser (Corporate / M&amp;A).

Homburger advised Crown Packaging European Division GmbH on its acquisition of Helvetia Packaging AG

Financing and Investment Products

IP / IT

Competition

Regulatory

Employment and Executive Compensation

On July 13, 2023, Homburger received the «Impact Deal of the Year» award at the LMG Life Sciences Awards EMEA 2023 for its work on <a href="https://www.homburger.ch/en/news/homburger-advises-csl-with-respect-to-its-announced-public-tender-offer-to-acquire-vifor-pharma">CSL/Vifor</a>. Our team was led by partners Dieter Gericke and Daniel Häusermann. It also included members from our Tax, Financing and Investment Products, Competition and Regulatory, IP / IT, Corporate/M&amp;A, and Employment and Executive Compensation teams.
The awards aim to recognize complex and impactful work across an array of legal specialisms that operate within the life sciences industry.

Homburger honored with LMG Life Sciences EMEA award for «Impact Deal of the Year»

Francesco
Bernasconi

Homburger advised TOLREMO therapeutics AG on the extension of its Series A financing round

Homburger advised Crown Packaging European Division GmbH on its acquisition of Helvetia Packaging AG

Homburger honored with LMG Life Sciences EMEA award for «Impact Deal of the Year»

Unzulässigkeit von erleichterten Fusionen nach Art. 23 Abs. 1 lit. b FusG bei indirekten Beteiligungsverhältnissen

Join the Team

Francesco Bernasconi

Career

Languages

Bar Registration

Teams

FrancescoBernasconi

Homburger advised TOLREMO therapeutics AG on the extension of its Series A financing round

Homburger advised Crown Packaging European Division GmbH on its acquisition of Helvetia Packaging AG

Homburger honored with LMG Life Sciences EMEA award for «Impact Deal of the Year»

Unzulässigkeit von erleichterten Fusionen nach Art. 23 Abs. 1 lit. b FusG bei indirekten Beteiligungsverhältnissen

Join the Team

Francesco Bernasconi

Career

Languages

Bar Registration

Teams

Francesco
Bernasconi

Unzulässigkeit von erleichterten Fusionen nach Art. 23 Abs. 1 lit. b FusG bei indirekten Beteiligungsverhältnissen